Trials / Completed
CompletedNCT06349655
The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19
Real-World Effectiveness and Safety of Oral Azvudine in Hospitalized Patients With COVID-19: A Multicenter, Retrospective, Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 32,864 (actual)
- Sponsor
- The First Affiliated Hospital of Zhengzhou University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To establish a real-world clinical cohort and database of Azvudine in the treatment of SARS-CoV-2 infection, and to provide stable and reliable evidence for the clinical efficacy and safety evaluation of azvudine in the treatment of SARS-CoV-2 infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azvudine | Antiviral drug |
| DRUG | Paxlovid | Antiviral drug |
Timeline
- Start date
- 2023-12-05
- Primary completion
- 2024-01-15
- Completion
- 2024-03-10
- First posted
- 2024-04-05
- Last updated
- 2024-04-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06349655. Inclusion in this directory is not an endorsement.